Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
LetterLetters to the Editor

Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the Details

Glenn D. Flux, Frederik A. Verburg, Carlo Chiesa, Manuel Bardiès, Katarina Sjögreen Gleisner, Barbara Hertz, Mark Konijnenberg, Michael Lassmann, Michael Ljungberg, Markus Luster, Michael Stabin and Lidia Strigari
Journal of Nuclear Medicine May 2017, 58 (5) 862; DOI: https://doi.org/10.2967/jnumed.116.186643
Glenn D. Flux
*Royal Marsden Hospital Downs Rd. Sutton, Su SM2 5PT, United Kingdom E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: glenn.flux@icr.ac.uk
Frederik A. Verburg
*Royal Marsden Hospital Downs Rd. Sutton, Su SM2 5PT, United Kingdom E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: glenn.flux@icr.ac.uk
Carlo Chiesa
*Royal Marsden Hospital Downs Rd. Sutton, Su SM2 5PT, United Kingdom E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: glenn.flux@icr.ac.uk
Manuel Bardiès
*Royal Marsden Hospital Downs Rd. Sutton, Su SM2 5PT, United Kingdom E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: glenn.flux@icr.ac.uk
Katarina Sjögreen Gleisner
*Royal Marsden Hospital Downs Rd. Sutton, Su SM2 5PT, United Kingdom E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: glenn.flux@icr.ac.uk
Barbara Hertz
*Royal Marsden Hospital Downs Rd. Sutton, Su SM2 5PT, United Kingdom E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: glenn.flux@icr.ac.uk
Mark Konijnenberg
*Royal Marsden Hospital Downs Rd. Sutton, Su SM2 5PT, United Kingdom E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: glenn.flux@icr.ac.uk
Michael Lassmann
*Royal Marsden Hospital Downs Rd. Sutton, Su SM2 5PT, United Kingdom E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: glenn.flux@icr.ac.uk
Michael Ljungberg
*Royal Marsden Hospital Downs Rd. Sutton, Su SM2 5PT, United Kingdom E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: glenn.flux@icr.ac.uk
Markus Luster
*Royal Marsden Hospital Downs Rd. Sutton, Su SM2 5PT, United Kingdom E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: glenn.flux@icr.ac.uk
Michael Stabin
*Royal Marsden Hospital Downs Rd. Sutton, Su SM2 5PT, United Kingdom E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: glenn.flux@icr.ac.uk
Lidia Strigari
*Royal Marsden Hospital Downs Rd. Sutton, Su SM2 5PT, United Kingdom E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: glenn.flux@icr.ac.uk
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 58 no. 5 862
DOI 
https://doi.org/10.2967/jnumed.116.186643
PubMed 
28183989

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 1, 2017.

Article Versions

  • previous version (February 9, 2017 - 04:22).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

Statistics from Altmetric.com

Cited By...

  • 7 Citations
  • 8 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer
    Kevin J. Donohoe, Jennifer Aloff, Anca M. Avram, K.G. Bennet, Luca Giovanella, Bennett Greenspan, Seza Gulec, Aamna Hassan, Richard T. Kloos, Carmen C. Solórzano, Brendan C. Stack, Mark Tulchinsky, Robert Michael Tuttle, Douglas Van Nostrand, Jason A. Wexler
    Journal of Nuclear Medicine 2020 61 3
  • Factors Associated with Dose Determination of Radioactive Iodine Therapy for Differentiated Thyroid Cancer
    Chae Moon Hong, Byeong-Cheol Ahn
    Nuclear Medicine and Molecular Imaging 2018 52 4
  • Radiotheragnostics Paradigm for Radioactive Iodine (Iodide) Management of Differentiated Thyroid Cancer
    Einat Slonimsky, Mark Tulchinsky
    Current Pharmaceutical Design 2020 26 31
  • Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer
    Massimiliano Pacilio, Miriam Conte, Viviana Frantellizzi, Maria Silvia De Feo, Antonio Rosario Pisani, Andrea Marongiu, Susanna Nuvoli, Giuseppe Rubini, Angela Spanu, Giuseppe De Vincentis
    Diagnostics 2022 12 7
  • Radiation protection in therapy with radiopharmaceuticals
    Makoto Hosono
    International Journal of Radiation Biology 2019 95 10
  • Fixed 3.7-GBq 131I Activity for Metastatic Thyroid Cancer Therapy Ignores Science and History
    Walter Jentzen, Alan E. Nahum, Andreas Bockisch, Ina Binse, Mark Tulchinsky
    Journal of Nuclear Medicine 2017 58 9
  • The internal dosimetry user group position statement on molecular radiotherapy
    Jonathan Gear, Daniel McGowan, Bruno Rojas, Allison J Craig, April-Louise Smith, Catherine J Scott, James Scuffam, Matthew Aldridge, Jill Tipping
    The British Journal of Radiology 2021 94 1126
  • Basic Sciences of Nuclear Medicine
    Magdy M. Khalil
    2021

Article usage

Article usage: February 2017 to February 2023

AbstractFullPdf
Feb 20172069
Mar 20172032
Apr 20173015
May 201737225106
Jun 201705124
Jul 201702116
Aug 20170297
Sep 20170318
Oct 201704320
Nov 201702516
Dec 201701611
Jan 201801315
Feb 20180917
Mar 201802024
Apr 201801316
May 201801522
Jun 201801447
Jul 20180414
Aug 2018098
Sep 201802324
Oct 201831828
Nov 201801321
Dec 201802235
Jan 201902029
Feb 201901221
Mar 20190923
Apr 201901117
May 201901910
Jun 20190259
Jul 201901918
Aug 201901011
Sep 20190197
Oct 20190165
Nov 20190199
Dec 20190126
Jan 20200101
Feb 20200158
Mar 202031610
Apr 20200262
May 202012215
Jun 20200184
Jul 2020061
Aug 20200156
Sep 20200146
Oct 2020095
Nov 20200157
Dec 20200121
Jan 202104813
Feb 202101811
Mar 202102020
Apr 202101917
May 202102210
Jun 202102514
Jul 202102017
Aug 20210156
Sep 202102111
Oct 202101713
Nov 202101318
Dec 20210145
Jan 202202213
Feb 2022095
Mar 20220169
Apr 2022046
May 20220814
Jun 202201514
Jul 20220294
Aug 20220139
Sep 202201311
Oct 20220610
Nov 20220183
Dec 2022091
Jan 20230246
Feb 20230101
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 58 (5)
Journal of Nuclear Medicine
Vol. 58, Issue 5
May 1, 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the Details
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the Details
Glenn D. Flux, Frederik A. Verburg, Carlo Chiesa, Manuel Bardiès, Katarina Sjögreen Gleisner, Barbara Hertz, Mark Konijnenberg, Michael Lassmann, Michael Ljungberg, Markus Luster, Michael Stabin, Lidia Strigari
Journal of Nuclear Medicine May 2017, 58 (5) 862; DOI: 10.2967/jnumed.116.186643

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the Details
Glenn D. Flux, Frederik A. Verburg, Carlo Chiesa, Manuel Bardiès, Katarina Sjögreen Gleisner, Barbara Hertz, Mark Konijnenberg, Michael Lassmann, Michael Ljungberg, Markus Luster, Michael Stabin, Lidia Strigari
Journal of Nuclear Medicine May 2017, 58 (5) 862; DOI: 10.2967/jnumed.116.186643
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer
  • Fixed 3.7-GBq 131I Activity for Metastatic Thyroid Cancer Therapy Ignores Science and History
  • Google Scholar

More in this TOC Section

  • Theranostic Digital Twins: An Indispensable Prerequisite for Personalized Cancer Care
  • Dosimetry in Radiopharmaceutical Therapy
  • Reply: Dosimetry in Radiopharmaceutical Therapy
Show more Letters to the Editor

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire